Eli Lilly and more: Strategist names 5 stocks set for ‘significant’ earnings growth
"You really have to dig into individual companies and sectors," says the T. Rowe Price strategist, naming some of his
Read More"You really have to dig into individual companies and sectors," says the T. Rowe Price strategist, naming some of his
Read MoreThe firm recommended a "barbell" of traditional defensive stocks, some select growth opportunities and late-cycle cyclical names. Source link
Read MoreThe firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640
Read MoreNames on the move ahead of the open. Source link
Read MoreBlue Shield's announcement hints at the potential for health insurers to abandon the traditional PBM system. Source link
Read MoreOle Andreas Halvorsen's Viking Capital cut its holdings in Amazon and insurance companies in the second quarter. Source link
Read MoreThe results ease investor concerns after Humana and rival UnitedHealth Group warned of a surge in demand for nonurgent surgeries
Read MoreThe results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products
Read MoreHere are the biggest calls on Wall Street on Source link
Read More